• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于炎症的评估用于心力衰竭患者死亡风险分层。

Inflammation-based assessment for the risk stratification of mortality in patients with heart failure.

机构信息

Department of Cardiovascular Medicine, Ina Central Hospital, Ina, Japan.

Department of Cardiovascular Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.

出版信息

Sci Rep. 2021 Jul 22;11(1):14989. doi: 10.1038/s41598-021-94525-6.

DOI:10.1038/s41598-021-94525-6
PMID:34294776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8298574/
Abstract

The Glasgow Prognostic Score (GPS) has been established as a useful resource to evaluate inflammation and malnutrition and predict prognosis in several cancers. However, its prognostic significance in patients with heart failure (HF) is not well established. To investigate the association between the GPS and mortality in patients with HF, we assessed 870 patients who were 20 years old and more and had been admitted for acute decompensated HF. The GPS ranged from 0 to 2 points as previously reported. Over the 18-month follow-up (follow-up rate, 83.9%), 143 patients died. Increasing GPS was associated with higher HF severity assessed by New York Heart Association functional class and B-type natriuretic peptide (BNP) levels. Kaplan-Meier analysis showed significant associations for mortality and increased GPS. In multivariate analysis, compared to the GPS 0 group, the GPS 2 group was associated with high mortality (hazard ratio 2.92, 95% confidence interval 1.77-4.81, p < 0.001) after adjustment for age, sex, blood pressure, HF history, HF severity, hemoglobin, renal function, sodium, BNP, left ventricular ejection fraction, and anti-HF medications. In conclusion, high GPS was significantly associated with worse prognosis in patients with HF. Inflammation-based assessment by the GPS may enable simple evaluation of HF severity and prognosis.

摘要

格拉斯哥预后评分(GPS)已被确立为评估炎症和营养不良并预测多种癌症预后的有用资源。然而,其在心力衰竭(HF)患者中的预后意义尚未得到充分证实。为了研究 GPS 与 HF 患者死亡率之间的关系,我们评估了 870 名年龄在 20 岁及以上并因急性失代偿性 HF 入院的患者。GPS 范围如前所述为 0 至 2 分。在 18 个月的随访期间(随访率为 83.9%),有 143 名患者死亡。GPS 升高与纽约心脏协会功能分级和 B 型利钠肽(BNP)水平评估的 HF 严重程度更高相关。Kaplan-Meier 分析显示死亡率和 GPS 升高之间存在显著相关性。多变量分析显示,与 GPS 0 组相比,GPS 2 组与高死亡率相关(风险比 2.92,95%置信区间 1.77-4.81,p<0.001),校正年龄、性别、血压、HF 病史、HF 严重程度、血红蛋白、肾功能、钠、BNP、左心室射血分数和抗 HF 药物后。总之,高 GPS 与 HF 患者的预后较差显著相关。GPS 基于炎症的评估可能能够简单评估 HF 的严重程度和预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1c/8298574/46505bc547cf/41598_2021_94525_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1c/8298574/25464eb8819c/41598_2021_94525_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1c/8298574/8a88321ff2b8/41598_2021_94525_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1c/8298574/2697b1c10a81/41598_2021_94525_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1c/8298574/46505bc547cf/41598_2021_94525_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1c/8298574/25464eb8819c/41598_2021_94525_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1c/8298574/8a88321ff2b8/41598_2021_94525_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1c/8298574/2697b1c10a81/41598_2021_94525_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1c/8298574/46505bc547cf/41598_2021_94525_Fig4_HTML.jpg

相似文献

1
Inflammation-based assessment for the risk stratification of mortality in patients with heart failure.基于炎症的评估用于心力衰竭患者死亡风险分层。
Sci Rep. 2021 Jul 22;11(1):14989. doi: 10.1038/s41598-021-94525-6.
2
The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.B型利钠肽在亚洲人群住院急性失代偿性心力衰竭中的应用及预后影响
BMC Cardiovasc Disord. 2016 Sep 9;16(1):178. doi: 10.1186/s12872-016-0342-z.
3
How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.我们需要多久测量一次因急性重度心力衰竭住院患者的脑利钠肽(BNP)血液水平?连续测量在改善短期预后分层中的作用。
Int J Cardiol. 2010 Apr 1;140(1):88-94. doi: 10.1016/j.ijcard.2008.11.020. Epub 2009 Mar 24.
4
Meta-Analysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: Validation of a Simple Tool for the Prediction of Morbidity and Mortality in Heart Failure With Preserved Ejection Fraction.Meta-Analysis Global Group in Chronic (MAGGIC) 心力衰竭风险评分:验证一种简单工具预测射血分数保留的心力衰竭患者的发病率和死亡率的有效性。
J Am Heart Assoc. 2018 Oct 16;7(20):e009594. doi: 10.1161/JAHA.118.009594.
5
Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.验证 MAGGIC(慢性心力衰竭全球荟萃分析协作组)心力衰竭风险评分以及添加利钠肽对住院心力衰竭患者出院后死亡率预测的影响。
PLoS One. 2018 Nov 28;13(11):e0206380. doi: 10.1371/journal.pone.0206380. eCollection 2018.
6
Natriuretic peptide system is not exhausted in severe heart failure.利钠肽系统在严重心力衰竭中并未耗竭。
J Cardiovasc Med (Hagerstown). 2009 Jan;10(1):39-43. doi: 10.2459/jcm.0b013e328319679f.
7
Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.因新发诊断或恶化的慢性心力衰竭住院:来自 ASCEND-HF 试验。
J Am Coll Cardiol. 2017 Jun 27;69(25):3029-3039. doi: 10.1016/j.jacc.2017.04.043.
8
Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.急性失代偿性心力衰竭患者入院时B型利钠肽水平与院内死亡率
J Am Coll Cardiol. 2007 May 15;49(19):1943-50. doi: 10.1016/j.jacc.2007.02.037. Epub 2007 Apr 30.
9
Predictors of Six-Month Mortality in BNP-Matched Acute Heart Failure Patients.BNP匹配的急性心力衰竭患者6个月死亡率的预测因素
Am J Cardiol. 2015 Sep 1;116(5):744-8. doi: 10.1016/j.amjcard.2015.05.046. Epub 2015 Jun 3.
10
B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.B 型利钠肽与射血分数保留和降低心力衰竭患者的预后。
J Am Coll Cardiol. 2013 Apr 9;61(14):1498-506. doi: 10.1016/j.jacc.2012.12.044.

引用本文的文献

1
Systemic inflammation-based Glasgow Prognostic Score as a prognostic indicator in chronic heart failure.基于全身炎症的格拉斯哥预后评分作为慢性心力衰竭的预后指标
Int J Cardiol Heart Vasc. 2025 Apr 4;58:101660. doi: 10.1016/j.ijcha.2025.101660. eCollection 2025 Jun.
2
Hypoalbuminaemia and heart failure: A practical review of current evidence.低白蛋白血症与心力衰竭:当前证据的实用综述
Eur J Heart Fail. 2025 Feb;27(2):293-306. doi: 10.1002/ejhf.3363. Epub 2024 Jul 4.
3
Correlations between soluble ST2 concentration and the nutritional status in patients with heart failure with reduced ejection fraction - cross-sectional study.

本文引用的文献

1
Clinical characteristics and prognostic factors in elderly patients with chronic heart failure -A report from the CHART-2 study.老年慢性心力衰竭患者的临床特征及预后因素——CHART-2研究报告
Int J Cardiol Heart Vasc. 2020 Mar 20;27:100497. doi: 10.1016/j.ijcha.2020.100497. eCollection 2020 Apr.
2
The inflammation-based modified Glasgow prognostic score is associated with survival in stable heart failure patients.基于炎症的改良格拉斯哥预后评分与稳定型心力衰竭患者的生存率相关。
ESC Heart Fail. 2020 Apr;7(2):654-662. doi: 10.1002/ehf2.12625. Epub 2020 Feb 25.
3
Modified Glasgow Prognostic Score is a novel predictor of clinical outcome in heart failure with preserved ejection fraction.
射血分数降低的心力衰竭患者可溶性ST2浓度与营养状况的相关性——横断面研究
Cardiol J. 2024;31(6):850-860. doi: 10.5603/cj.96062. Epub 2024 May 14.
4
The Metabolic Vulnerability Index: A Novel Marker for Mortality Prediction in Heart Failure.代谢脆弱性指数:心力衰竭患者死亡率预测的新标志物。
JACC Heart Fail. 2024 Feb;12(2):290-300. doi: 10.1016/j.jchf.2023.06.013. Epub 2023 Jul 19.
5
Inflammageing and Cardiovascular System: Focus on Cardiokines and Cardiac-Specific Biomarkers.炎症与心血管系统:聚焦细胞因子和心脏特异性生物标志物。
Int J Mol Sci. 2023 Jan 3;24(1):844. doi: 10.3390/ijms24010844.
6
Prognostic Value of Routinely Measured Inflammatory Biomarkers in Older Cancer Patients: Pooled Analysis of Three Cohorts.老年癌症患者常规检测的炎症生物标志物的预后价值:三个队列的汇总分析
Cancers (Basel). 2021 Dec 7;13(24):6154. doi: 10.3390/cancers13246154.
改良的格拉斯哥预后评分是射血分数保留心力衰竭临床结局的新型预测指标。
Scand Cardiovasc J. 2020 Jun;54(3):174-178. doi: 10.1080/14017431.2019.1709656. Epub 2020 Jan 22.
4
The relevance of serum albumin among elderly patients with acute decompensated heart failure.血清白蛋白在老年急性失代偿性心力衰竭患者中的相关性。
J Geriatr Cardiol. 2019 Jul;16(7):522-528. doi: 10.11909/j.issn.1671-5411.2019.07.005.
5
Heart failure drug treatment.心力衰竭药物治疗。
Lancet. 2019 Mar 9;393(10175):1034-1044. doi: 10.1016/S0140-6736(18)31808-7.
6
Malnutrition in Heart Failure: Important But Undervalued Issue.心力衰竭中的营养不良:重要但被低估的问题。
JACC Heart Fail. 2018 Jun;6(6):487-488. doi: 10.1016/j.jchf.2018.03.014. Epub 2018 May 9.
7
Glasgow Prognostic Score is superior to ECOG PS as a prognostic factor in patients with gastric cancer with peritoneal seeding.在伴有腹膜播散的胃癌患者中,格拉斯哥预后评分作为预后因素优于东部肿瘤协作组体能状态评分。
Oncol Lett. 2018 Apr;15(4):4193-4200. doi: 10.3892/ol.2018.7826. Epub 2018 Jan 19.
8
Inflammation - Cause or Consequence of Heart Failure or Both?炎症——是心力衰竭的原因、后果还是两者皆是?
Curr Heart Fail Rep. 2017 Aug;14(4):251-265. doi: 10.1007/s11897-017-0337-9.
9
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.2017年美国心脏病学会/美国心脏协会/美国心力衰竭学会对2013年美国心脏病学会基金会/美国心脏协会心力衰竭管理指南的重点更新:美国心脏病学会/美国心脏协会临床实践指南工作组及美国心力衰竭学会的报告
J Am Coll Cardiol. 2017 Aug 8;70(6):776-803. doi: 10.1016/j.jacc.2017.04.025. Epub 2017 Apr 28.
10
Mode of Death in Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭患者的死亡模式。
J Am Coll Cardiol. 2017 Feb 7;69(5):556-569. doi: 10.1016/j.jacc.2016.10.078.